Business Daily Media

The Times Real Estate

.

China Biotech (8037.HK): Anticipating promising results from cell therapy and from precision diagnostics

  • Written by ACN Newswire - Press Releases
HONG KONG, Jun 28, 2021 - (ACN Newswire) - 2021-6-23 / Gelonghui - China Biotech's cell therapy was approved by the NMPA to enter Phase I clinical trials as a Class I new drug, while the recent CAR-T cell therapy approval for product marketing in China means a new era of immune cell therapy has begun.
Source: official website of NMPA
image
China Biotech (8037.HK): Anticipating promising results from cell therapy and from precision diagnostics
China Biotech (8037.HK): Anticipating promising results from cell therapy and from precision diagnostics
According to

Read more //?#

NextOre Unveils World First MR Analyser for Underground Copper Trucks

NextOre, a global leader in  Magnetic Resonance (MR)-enabled bulk ore sorting technology, has now made its world first sensor system available for...

Incode joins Australia’s Age Assurance Technology Trial to protect children online

With a market-leading +99% accuracy rate, Incode will play a key role in safeguarding Aussie minors on social media Incode Technologies Inc., a...

Empowering small businesses: Localsearch rolls out affordable digital solutions

New suite of digital solutions designed to boost visibility, engagement, and customer acquisition In response to a rapidly evolving digital lan...

Why Responsible Leadership is a Competitive Advantage for Small Businesses

In today’s fast-changing business landscape, leadership is evolving. While large corporations are reassessing their diversity, equity, and inclusi...

Why it’s a great time to include the EU in your export push

With the US market beset with unknowns, training your sights on mainland Europe in 2025 makes sound sense. Wondering whether the introduction o...

Success Isn’t About Labels—It’s About Mindset

In the lead up to International Women’s Day, I’ve been reflecting on my own success as a business owner and whether or not being a woman has playe...

Sell by LayBy